New WHO Public Assessment Report (WHOPAR) published
M
Past News
13th Invitation for Expression of Interest (EOI) for Active Pharmaceutical Ingredients (APIs) for prequalification
M
The following active pharmaceutical ingredients (APIs) were added:
- Azithromycin
- Miltefosine
- Paromomycin
- Sodium stibogluconate (SB5+)
First rifapentine product prequalified
M
-
TB336: Rifapentine - 150mg - Film-coated tablets - Sanofi-Aventis U.S. LLC - USA
5th Invitation to Manufacturers of Medicinal Products for Treatment of Neglected Tropical Diseases
M
The following products were added:
-
Miltefosine 10mg and 50mg capsule
BTIF revised
M
The revisions to the BTIF (Bioequivalence Trial Information Form) include the following changes to facilitate study assessment:
The Medicines Patent Pool Announces First Licence for Tuberculosis Treatment
M
The Medicines Patent Pool today announced that it has signed a licence w
12th Invitation for Expression of Interest (EOI) for Active Pharmaceutical Ingredients (APIs) for prequalification
M
The following active pharmaceutical ingredients (APIs) were added:
- Benzathine benzylpen
Newly prequalified Quality Control Laboratory (QCL)
M
New addition to the List of Prequalified Quality Control Laboratories (QCL):
8th Invitation for Expression of Interest (EOI) to manufacturers of Reproductive Health products
M
The following products were added:
Treatment of maternal syphilis and prevention of congenital syphilis
Adult formulations
Newly Prequalified Active Pharmaceutical Ingredient (API)
M
Medroxyprogesterone manufactured by Taizhou Taifa Pharmaceutical Co Ltd has been prequalified by the WHO Prequalification Team: medicines (PQTm) under its API prequalification procedure.
8 products newly prequalified
M
WHO Prequalification Team - Medicines (PQT) added the below new products to its prequalified list
Newly Prequalified Active Pharmaceutical Ingredients (APIs)
M
Cycloserine manufactured by Zhejiang Hisun Pharmaceutical Co Ltd and Zinc (sulfate) manufactured by Canton Laboratories Pvt Ltd have been prequalified by the WHO Prequalification Team: medicines (P
7 products newly prequalified
M
-
DI005: Zinc (as sulfate monohydrate) - 20mg - Dispersible tablets - Macleods Pharmaceuticals Ltd - INDIA
Misoprostol from China Resources Zizhu Pharmaceutical prequalified
M
RH048: Misoprostol - 200µg - Tablets - China Resources Zizhu Pharmaceutical Co Ltd - CHINA
Newly Prequalified Active Pharmaceutical Ingredient (API)
M
Dihydroartemisinin manufactured by Ipca Laboratories Ltd has been prequalified by the WHO Prequalification Team: medicines (PQTm) under its API prequalification procedure.
2 products newly prequalified
M
WHO Prequalification Team - Medicines (PQT) adds the below new products to its prequalified list
2 products newly prequalified
M
WHO Prequalification Team - Medicines (PQT) adds the below new products to its prequalified list
11th Invitation for Expression of Interest (EOI) for Active Pharmaceutical Ingredients (APIs)
M
The 11th invitation to manufacturers of active pharmaceutical ingredients (APIs) to submit an expression of interest (EOI) for API prequalification to the WHO Prequalification Team: medicines (PQTm
14th Invitation for Expression of Interest (EOI) for antituberculosis medicines published
M
The following products were added to the EOI:
New TB product prequalified
M
WHO Prequalification Team - Medicines (PQT) added the below new product to its prequalified list:
Newly-prequalified active pharmaceutical ingredient (API)
M
Levofloxacin manufactured by Shangyu Jingxin Pharmaceutical Co Ltd has been prequalified by the WHO Prequalification Team: medicines (PQTm) under its API prequalification procedure.
3 products newly prequalified
M
WHO Prequalification Team - Medicines (PQT) added the below new products to its prequalified list
Second diethylcarbamazine prequalified
M
WHO Prequalification Team - Medicines (PQT) added the below new product to its prequalified list:
Newly-prequalified active pharmaceutical ingredients (APIs)
M
Lumefantrine manufactured by Micro Labs Ltd and Lopinavir manufactured by Acebright (India) Pharma Pvt Ltd have been prequalified by the WHO Prequalification Team: medicines (PQTm) under its API pr
4 products newly prequalified
M
WHO Prequalification Team - Medicines (PQT) added the below new products to its prequalified list
WHO updates patent information on treatments for Hepatitis C
M
Visit the WHO website for updates on patent information on treatments for Hepatitis C
10th Invitation to Manufacturers of Reproductive Health Medicines to Submit an Expression of Interest (EOI) for Product Evaluation by the WHO Expert Review Panel (ERP) for Reproductive Health Medicines
M
The lack of prequalified reproductive health medicines is of great concern to WHO and to partner organizations working to improve reproductive health.